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Primary care physicians (PCPs) provide diabetes care for 82% of patients with type 2 
diabetes (1). Many patients with type 2 diabetes will eventually need insulin. The 
UKPDS (2) showed that ß-cell failure is progressive. From 50% of normal ß-cell function 
present at diagnosis, there is a steady decline with almost complete loss of ß-cell mass 
within 10-15 years, even earlier in some patients. On average, as many as 40-80% of 
patients with type 2 diabetes will need insulin within 10 years after diagnosis (1,2). These 
statistics can vary between patients and depending on the different agents used after the 
initial diagnosis. UKPDS did not include thiazolidinediones or GLP-1 based therapies, 
which could potentially have a completely different effect on the ß-cells and perhaps 
delay the need for insulin. 
 
Since many patients with type 2 diabetes need insulin at some point, and since most of 
these patients are under the care of a PCP, initiation of insulin therapy should be part of 
the daily routine in any PCP practice. However, it is not surprising to me that “…the 
initiation of insulin is one of the most difficult aspects of managing my patients with type 
2 diabetes.” This statement comes from two thirds of primary care physicians (PCPs) 
surveyed in the study by Hayes et al (3). In this issue of the International Journal of 
Clinical Practice, Hayes et al (3) surveyed 505 primary care physicians practicing in the 
United States. The survey was done via an internet site and included a demographic 
assessment, a question about glycemic goals and 30 belief items related to different 
aspects of insulin therapy. Most PCPs agreed that the benefits of using insulin to prevent 
or delay complications outweighed the risks of hypoglycemia and weight gain for most 
patients. They also agreed that a major barrier to initiating insulin was the patients’ fear 
and reluctance. However, there was a clear dichotomy when it came to the belief that 
most patients would need insulin at some point raising the question of whether PCPs truly 
understand the progressive decline in ß-cell function. Much more alarming was the 
question related to insulin metabolic effects; 35% of respondents believed that insulin 
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therapy would increase the risk of cardiovascular events; 33% were neutral and only 32% 
of the total group disagreed. 
 
Difficulty in initiating insulin therapy in patients with type 2 diabetes is a two-fold 
problem because of patients’ related barriers and PCPs’ lack of knowledge and resources.  
 
Patients have many concerns regarding insulin (4); one of the justifiable concerns is 
hypoglycemia, but for many, the major concern is related to the misconception that 
insulin could lead to more complications. In many patients’ minds, insulin is linked to 
hemodialysis or leg amputation or terminal illness. This misconception stems in part from 
many physicians’ reluctance to start insulin until their patients are maximized on oral 
agents and have reached an advance stage of uncontrolled hyperglycemia where 
complications are already overt. Many physicians also threaten their patients with insulin, 
creating feelings of personal failure or “doom” if insulin is initiated (5). Patients also 
want to avoid injections because in their mind, injections can be painful and difficult to 
do. Some may also see insulin injections as a social stigma. 
To overcome all these patients’ fears and misconceptions, teaching and education are 
paramount, especially at the time of diagnosis. In my opinion, all patients with newly 
diagnosed type 2 diabetes must attend individual or group education classes run by 
certified diabetes educators. They need to understand their disease, the natural history, 
the probable need for insulin at some point, the benefits of insulin therapy and the ease of 
injections now provided by pen devices and small needles. Understanding all these 
concepts make the transition to insulin much easier for most patients and physicians. 
However, even if patient barriers are lifted, we still have another major problem: PCPs’ 
lack of knowledge when it comes to insulin therapy. 
 
Few studies have looked at factors that contribute to physician reluctance to initiate 
insulin therapy. An international survey of over 3600 nurses and doctors in 13 countries 
revealed that clinicians who delay initiating insulin therapy have also delayed initiating 
oral medication, and that specialists and opinion leaders were less inclined than PCPs to 
delay starting insulin (4). US physicians were more likely to delay insulin, compared to 
physicians from 11 other countries. Riddle (6) noted the underuse of insulin in North 
America and pointed appropriately that some PCPs still worry that insulin therapy may 
promote insulin resistance or increase the risk of cardiovascular events; both being a 
major concern for many PCPs in the survey by Hayes et al (3). These beliefs are largely 
unfounded based on current evidence (7) and probably are the result of lack of knowledge. 
Similar problems related to insulin initiation affect practices of family physicians. A 
survey (8) of family physicians and patients regarding different aspects of insulin therapy 
showed that the physicians’ knowledge was low and many had misconceptions of 
patients’ fears, all contributing to a major delay in initiating insulin. Although specialists 
(endocrinologists, diabetologists) are less prone to clinical inertia in response to 
inadequate glycemic control, and are much more aggressive than PCPs in initiating 
insulin, one study showed that fewer than one-half of patients with high A1c levels had 
intensification of their medications, regardless of their physician (9). The major 
differences between specialists and PCPs are mostly the closer and better focus to 
diabetes issues during patients visits to a specialist clinic. The whole visit revolves 
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around diabetes as opposed to PCPs who have to take care of other medical issues during 
a similar time slot. Specialists also have better and easier access to patient education 
resources (certified diabetes educators, diabetes education classes, dieticians), which 
provide a major help in insulin initiation, titration and attainment of better glycemic 
control (10).  
 
Assuming we provide PCPs with all the necessary resources to treat diabetics and initiate 
insulin (more allotted time to see patients, certified diabetes educators, etc), would this 
solve the entire problem? Probably not.  Because PCPs may lack knowledge regarding 
many aspects of diabetes in general and insulin therapy in particular. The need for more 
teaching and continuing medical education is essential. In fact, we may need to go back 
to medical schools’ curriculums and make changes; medical students should be given 
more time to study diabetes and its treatment. House staff (interns and residents) should 
be exposed to more outpatient diabetes management. The current medical training system  
does not prepare physicians, when graduating from internal medicine programs, to 
adequately treat patients with diabetes (11).  
 
In order to provide our diabetics with the best care, many changes in our health care 
system need to take place as part of a worldwide reform which will involve medical 
schools, internal medicine programs, continuing medical education providers, health 
insurance industry, medical malpractice, hospitals and outpatient practices infrastructure 
and most importantly physician’s mentality. This reform will only happen if we all unite 
and have as a common goal our patients’ interest as outlined in the Hippocratic Oath.  
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